Sensei Biotherapeutics Inc. (NASDAQ: SNSE)
$0.70
-0.0175 ( -2.44% ) 40.9K
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.
Market Data
Open
$0.70
Previous close
$0.72
Volume
40.9K
Market cap
$18.06M
Day range
$0.70 - $0.74
52 week range
$0.51 - $1.94
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Nov 06, 2023 |
8-k | 8K-related | 55 | Nov 03, 2023 |
4 | Insider transactions | 1 | Nov 02, 2023 |
3 | Insider transactions | 2 | Nov 02, 2023 |
8-k | 8K-related | 13 | Oct 20, 2023 |
4 | Insider transactions | 1 | Sep 13, 2023 |
4 | Insider transactions | 1 | Sep 11, 2023 |
4 | Insider transactions | 1 | Sep 11, 2023 |
4 | Insider transactions | 1 | Sep 11, 2023 |
4 | Insider transactions | 1 | Sep 11, 2023 |